These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5917141)

  • 21. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
    Yamano M; Yuki H; Yasuda S; Miyata K
    J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The stimulus effects of serotonergic hallucinogens in animals.
    Winter JC
    NIDA Res Monogr; 1994; 146():157-82. PubMed ID: 8742798
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
    Parker MA; Marona-Lewicka D; Kurrasch D; Shulgin AT; Nichols DE
    J Med Chem; 1998 Mar; 41(6):1001-5. PubMed ID: 9526575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristic pharmacological properties of a number of antidepressants in repeated administration].
    Andreeva NI; Mashkovskiĭ MD
    Farmakol Toksikol; 1984; 47(2):19-23. PubMed ID: 6538850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The ethnopharmacology of hallucinogens: from "primitive rites" to their "presence" on TV. Proposals for the year 2000].
    Cugurra F
    Clin Ter; 1996 Nov; 147(11):537-42. PubMed ID: 9264906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Narcotic/sedative receptor antagonists.
    Jeske AH; Redden RJ
    J Gt Houst Dent Soc; 1993 May; 64(10):12-4; quiz 15. PubMed ID: 7905743
    [No Abstract]   [Full Text] [Related]  

  • 27. The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings].
    Valentino RJ; Herling S; Woods JH
    Psychopharmacol Bull; 1981 Jan; 17(1):51-4. PubMed ID: 7195052
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis.
    Pallesen S; Molde H; Arnestad HM; Laberg JC; Skutle A; Iversen E; Støylen IJ; Kvale G; Holsten F
    J Clin Psychopharmacol; 2007 Aug; 27(4):357-64. PubMed ID: 17632219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of pharmacological action of antidepressants].
    Encephale; 1980; 6(4):393-6. PubMed ID: 7439116
    [No Abstract]   [Full Text] [Related]  

  • 30. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
    Votava Z; Podvalová I; Vojtĕchovský M
    Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083
    [No Abstract]   [Full Text] [Related]  

  • 31. Buprenorphine for depression: the un-adoptable orphan.
    Callaway E
    Biol Psychiatry; 1996 Jun; 39(12):989-90. PubMed ID: 8780832
    [No Abstract]   [Full Text] [Related]  

  • 32. Sigma receptors and sigma ligands: background to a pharmacological enigma.
    Leonard BE
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S166-70. PubMed ID: 15547782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On a new pharmacological action of antidepressants].
    Bourin M
    J Psychiatry Neurosci; 1994 Jan; 19(1):7-10. PubMed ID: 7908538
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anxiety; pharmacological bases of treatment].
    de Andrés Rodríguez-Trelles F
    An R Acad Nac Med (Madr); 1981; 98(1):69-116. PubMed ID: 6115590
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anomalies of the waking state under the effect of psychodysleptics (hallucinogens)].
    Rougeul A
    Laval Med; 1969 Jan; 40(1):37-41. PubMed ID: 5774368
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel agents for intractable itch.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2008 Feb; 13(1):6-9. PubMed ID: 18357364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sensitivity of opioid mediated stress analgesia to narcotic antagonists.
    Terman GW; Lewis JW; Liebeskind JC
    Proc West Pharmacol Soc; 1983; 26():49-52. PubMed ID: 6684295
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nonselective effect of selective antidepressants.
    Montgomery SA
    Adv Biochem Psychopharmacol; 1982; 32():49-55. PubMed ID: 6178265
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antidepressive agents: classification and mechanism of action].
    Cuenca E; Alamo C; Coullaut-Jáuregui J
    Rev Clin Esp; 1997 Nov; 197 Suppl 3():44-7. PubMed ID: 9477690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.